CompletedNot Applicable

French Translation and Validation of the PEYronie's Disease QUESTionnaire

France30 participantsStarted 2023-03-06

Plain-language summary

This study is a prospective cohort dedicated to peyronie's disease. The aim is to validate the french translation of the peyronie's disease questionnaire. The primary endpoint is the response rate to the questionnaire.

Who can participate

Age range18 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patient with Peyronie's Disease clinically diagnosed during a consultation, with palpation of at least one plaque Exclusion Criteria: * Patient refusing to participate * Patient with difficulties in understanding the French language. * Protected persons referred to in articles L.1121-6 to L.1121-8 of the public health code

What they're measuring

Rate of responses

Timeframe: Day 0

Trial details

NCT IDNCT05768867

SponsorUniversity Hospital, Toulouse

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-05-22

View on ClinicalTrials.gov More Peyronie Disease trials